StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health AFS Fixed Maturity by Maturity

AFS Fixed Maturity by Maturity — Mortgage-Backed Securities (Fair Value) ($M)

QuarterlyAnnual

Elevance Health AFS Fixed Maturity by Maturity: $8,151M in Q3 2026, up 55.6% from a year earlier. That is the highest of the 16 quarters on record here.

Latest, Q3 2026
8,151
Period ended Sep 30, 2026
Change on a year earlier
+55.6%
5,237 in Q3 2025
History
16 quarters
Since Q3 2022
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue (2026-09-30): 8,151,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Fixed Maturity by Maturity — Mortgage-Backed Securities (Fair Value) ($M)Year on yearSource
Q3 2026Sep 30, 20268,151+55.6%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q2 2026Jun 30, 20268,067+59.8%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q1 2026Mar 31, 20268,098+53.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q4 2025Dec 31, 20255,180+7.9%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q3 2025Sep 30, 20255,237-8.7%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q2 2025Jun 30, 20255,047-12.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q1 2025Mar 31, 20255,291-9.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q4 2024Dec 31, 20244,800-18.3%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q3 2024Sep 30, 20245,738+6.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q2 2024Jun 30, 20245,752+6.6%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q1 2024Mar 31, 20245,821+17.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q4 2023Dec 31, 20235,878–ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q3 2023Sep 30, 20235,408+25.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q2 2023Jun 30, 20235,397–ELV 10-Q/A (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q1 2023Mar 31, 20234,969–ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗
Q3 2022Sep 30, 20224,317–ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue) ↗

Cite this data

StockData. (2026). Elevance Health AFS Fixed Maturity by Maturity ($M), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-afs-maturity-mbs-fv

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.